Clarem 250 tablets film-coated

Land: Armenía

Tungumál: enska

Heimild: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Download Vara einkenni (SPC)
28-07-2016

Virkt innihaldsefni:

clarithromycin

Fáanlegur frá:

Remedica Ltd

ATC númer:

J01FA09

INN (Alþjóðlegt nafn):

clarithromycin

Skammtar:

250mg

Lyfjaform:

tablets film-coated

Einingar í pakka:

(14/2x7/) in blister

Gerð lyfseðils:

Prescription

Leyfisstaða:

Registered

Leyfisdagur:

2016-07-27

Vara einkenni

                                CLAREM 250 FC TABS-SPC-V1-03
1 of 8
Ref: CLAREM 250 FC TABS-SPC-V1-03
SUMMARY OF PRODUCT CHARACTERISTICS
_1. NAME OF THE MEDICINAL PRODUCT _
Clarem 250 Tablets
_2. QUALITATIVE AND QUANTITATIVE COMPOSITION _
Each Clarem 250 tablet contains 250mg Clarithromycin.
For full list of excipients refer to point 6.1.
_3. PHARMACEUTICAL FORM _
Film-Coated Tablets
_4. CLINICAL PARTICULARS _
_4.1. THERAPEUTIC INDICATIONS _
Clarem is indicated for treatment of infections caused by susceptible
organisms. Indications include:
Lower respiratory tract infections for example, acute and chronic
bronchitis, and pneumonia.
Upper respiratory tract infections for example, sinusitis and
pharyngitis.
Clarem is appropriate for initial therapy in community acquired
respiratory infections and has been
shown to be active in vitro against common and atypical respiratory
pathogens as listed in the
microbiology section.
Clarem is also indicated in skin and soft tissue infections of mild to
moderate severity.
Clarem in the presence of acid suppression effected by omeprazole or
lansoprazole is also indicated
for the eradication of _ H. pylori_ in patients with duodenal ulcers.
See Dosage and Administration
section.
Clarem is usually active against the following organisms _in vitro_:
Gram-positive Bacteria: _ Staphylococcus aureus_ (methicillin
susceptible); _ Streptococcus pyogenes_
(Group A beta-hemolytic streptococci), alpha-hemolytic streptococci
(viridans group_); Streptococcus _
_(Diplococcus) pneumoniae; Streptococcus agalactiae; Listeria
monocytogenes_.
Gram-negative
Bacteria:
_Haemophilus _
_influenzae, _
_Haemophilus _
_parainfluenzae, _
_Moraxella _
_(Branhamella) _
_catarrhalis, _
_Neisseria _
_gonorrhoeae; _
_Legionella _
_pneumophila, _
_Bordetella _
_pertussis, _
_Helicobacter pylori; Campylobacter jejuni._
Mycoplasma: _Mycoplasma pneumoniae; Ureaplasma urealyticum._
Other Organisms: _Chlamydia trachomatis; Mycobacterium avium;
Mycobacterium leprae._
Anaerobes: Macrolide-susceptible_ Bacteroides fragilis; Clostridium
perfringens_; Pe
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill rússneska 27-07-2016

Leitaðu viðvaranir sem tengjast þessari vöru